- Home
- TCI vs IMAB Comparison
TCI vs IMAB Comparison
Compare TCI & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCI
- IMAB
- Stock Information
- Founded
- TCI 1983
- IMAB 2014
- Country
- TCI United States
- IMAB United States
- Employees
- TCI N/A
- IMAB N/A
- Industry
- TCI Real Estate
- IMAB Biotechnology: Pharmaceutical Preparations
- Sector
- TCI Finance
- IMAB Health Care
- Exchange
- TCI Nasdaq
- IMAB Nasdaq
- Market Cap
- TCI 357.8M
- IMAB 384.6M
- IPO Year
- TCI N/A
- IMAB 2020
- Fundamental
- Price
- TCI $46.66
- IMAB $4.60
- Analyst Decision
- TCI
- IMAB Strong Buy
- Analyst Count
- TCI 0
- IMAB 5
- Target Price
- TCI N/A
- IMAB $6.80
- AVG Volume (30 Days)
- TCI 1.8K
- IMAB 2.0M
- Earning Date
- TCI 11-06-2025
- IMAB 11-02-2025
- Dividend Yield
- TCI N/A
- IMAB N/A
- EPS Growth
- TCI 11.20
- IMAB N/A
- EPS
- TCI 0.76
- IMAB N/A
- Revenue
- TCI $47,730,000.00
- IMAB N/A
- Revenue This Year
- TCI N/A
- IMAB N/A
- Revenue Next Year
- TCI N/A
- IMAB N/A
- P/E Ratio
- TCI $61.06
- IMAB N/A
- Revenue Growth
- TCI N/A
- IMAB N/A
- 52 Week Low
- TCI $25.50
- IMAB $0.60
- 52 Week High
- TCI $48.00
- IMAB $5.90
- Technical
- Relative Strength Index (RSI)
- TCI 56.16
- IMAB 57.10
- Support Level
- TCI $45.43
- IMAB $4.21
- Resistance Level
- TCI $47.00
- IMAB $4.60
- Average True Range (ATR)
- TCI 0.55
- IMAB 0.47
- MACD
- TCI -0.16
- IMAB -0.11
- Stochastic Oscillator
- TCI 47.86
- IMAB 38.46
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).